Company intelligence / Profile preview
Blue Cross Laboratories
- Ownership
- Private
- Employees
- ~3400
- Development stage
- Other
Overview
Blue Cross Laboratories markets more than 160 pharmaceutical products, focusing on high-quality, affordable generics across key therapeutic areas with a global presence in over 15 countries and WHO-GMP, ISO 9001:2015 certified manufacturing[1][2][3].
- Therapeutic areas
- EndocrinologyRheumatologyInfectious DiseasesGastroenterologyDermatologyCardiovascular
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Blue Cross Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Blue Cross Laboratories.